Antiverse
Designing functional antibodies for the most challenging targets.
33 employees · est. 2017 · Cardiff, United Kingdom
Confo Therapeutics
Exploiting the conformational complexity of GPCRs to innovate drug discovery
82 employees · est. 2015 · Zwijnaarde, Belgium
Confo Therapeutics is the older company (2017 vs 2015); Confo Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Antiverse | Confo Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2015 older |
| Headquarters | ||
| Headquarters | Cardiff, United Kingdom | Zwijnaarde, Belgium |
| Employees | ||
| Employees | 33 | 82 larger |
| Industry | ||
| Industry | AI, Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Grant |
| Total Funding | ||
| Total Funding | $21.82M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 10 | Not tracked yet |
| Services | ||
| Services | Antibody design for challenging targets, Pharmaceutical partnerships, In silico drug discovery, Machine learning model development | Development of GPCR-modulating therapies, Clinical research and development, Partnership with pharmaceutical companies, Small molecules and antibody therapeutics development, GPCR targeting technology innovation |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotech firms, Healthcare researchers | Patients with metabolic diseases, Patients with endocrine diseases, Pharmaceutical companies, Healthcare providers specializing in pain management, Research institutions |
| Taxonomy | ||
| Taxonomy | Antibody Design, Challenging Drug Targets, GPCR Therapeutics, Ion Channel Therapeutics, TechBio, Cell Line Engineering, De Novo Antibody Therapeutics, Drug Discovery, Structural Biology, Biotechnology Innovation, Therapeutic Antibodies, Accelerated Drug Development, Advanced Therapeutics | GPCR Drug Discovery, Conformational Stabilization, Biopharmaceuticals, Drug Candidates Development, Severe Illness Therapeutics, Disease-Modifying Treatments, Pharmacologic Insight, Biologic Insight, Innovative Drug Targets, CONFO® Technology, Active State Conformations, Novel Agonist Discovery, Antibody Technology, Multi-Indication Pipeline, Unmet Medical Needs |
| Website | ||
| Website | antiverse.io | confotherapeutics.com |
About Antiverse
Antiverse, founded in 2017, is a promising Welsh techbio company that specializes in the design of antibodies targeting difficult drug targets such as GPCRs and ion channels. The company’s mission is encapsulated in its slogan: "Designing functional antibodies for the most challenging targets." Wit...
About Confo Therapeutics
Confo Therapeutics, founded in 2015 and headquartered in Belgium, is a pioneering biotechnology company that leverages its proprietary technology platform to stabilize functional conformations of GPCRs (G protein-coupled receptors). This innovative approach uncovers a vast array of previously inacce...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Antiverse and Confo Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Antiverse and Confo Therapeutics — by email.
Frequently Asked Questions
Compare Antiverse with someone else
Start typing a company name or domain.